Notizen
Emergencies in Pediatric Oncology
Inhalt der Notizen (1)
Seite 1
Definition:
WBC > 100

Leukapheresis
treatment for extreme cases
lots of risks: electrolyte imbalance, hemorrhage, respiratory failure, renal failure, allergic reaction
need to be in ICU setting, pheresis trained nurse, central line, blood bank
INTERVENTIONS
-close monitoring
-fluids at 1.5-2x maintenance
-avoid PRBCs if possible
-give platelets, FFP, cryo PRN
-treat/monitor tumor lysis
-start chemo as soon as possible
-leukapheresis
More common in AML & infants
Affects overall prognosis, if symptomatic - higher risk of M&M
POSSIBLE COMPLICATIONS
-neuro: stroke, headache, blindness, decreased LOC
-respiratory: hypoxia, dyspnea
-hemorrhage
-renal failure
-tumor lysis syndrome
Result of the rapid destruction of malignant cells in bulky, rapidly proliferating tumors or in highly chemo-sensitive disease
Causes electrolyte imbalances
1. Elevated Uric Acid >8
2. Elevated Phosphorus >2.1
3. Elevated Potassium >6
4. Decreased Calcium

Cell damage = release of nucleic acid (which eventually is converted into uric acid)
Rapid release of phosphates as malignant cells have as much as 4x the amount of phosphate compared to normal cells
Can cause precipitation in the renal tubules, which can lead to renal failure
RISK FACTORS
-Diagnosis: Burkitt's leukemia & lymphoma, ALL, other lymphomas
-Increased LDH
-bulky disease
-initial WBC >25K
-uric acid >8
-serum creatnine 1.5x upper normal limit
COMPLICATIONS
Renal Insufficiency Cardiac Arrhythmias
Seizures
Clinical Manifestations
-Usually occur 12-72 hours after first chemo
nausea, vomiting
decreased urine output
edema, fluid overload
dysrhythmias
congestive heart failure
lethargy
muscle cramping
tetany
Supportive Care for Prevention & Treatment of TLS
IV Hydration
Baseline lab work; if abnormalities noted or high risk factors, repeat Q4-6 hours
Weight monitoring, fluid balance
Severe cases may require dialysis
****Best to use GFR or creatinine clearance as an indicator of acute renal failure****
ALLOPURINOL
-xanthine oxidase inhibitor
-reduces uric acid production
-give 10 mg/kg/day divided every 8-24 hours
-used in low-moderate risk patients as prevention
RASBURICASE
-enzyme found in other
mammals but not humans
-catabolizes existing uric acid to allantoin (much more soluble)
-0.05-0.2 mg/kg for single dose
-very expensive
HypErleukocytosis
Tumor lysis syndrome
Informationen
- Beschreibung
- Notiz am Emergencies in Pediatric Oncology, erstellt von CPHONexam am 18/07/2014.
- Erstellt von
- CPHONexam · Jul 2014
- Aktualisiert
- 6 Aug 2016
- Aufrufe
- 85
- Bewertung